Home › Lung Diseases › Arizona › Tucson
Lung Diseases clinical trials in Tucson, AZ
4 studies for Lung Diseases are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- The University of Arizona Cancer Center - North Campus, Tucson
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Tucson
American Lung Association (ALA) Lung Health Cohort
RecruitingObservational studyHealthy volunteers welcome
- University of Arizona-Tuscon, Tucson
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RecruitingPhase 2
- University of Arizona- Tuscon, Tucson
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX16 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY13 studies
- Pittsburgh, PA11 studies
- Dallas, TX10 studies
- Los Angeles, CA10 studies
- Ann Arbor, MI10 studies
- Miami, FL10 studies
- Columbus, OH10 studies
- Chicago, IL9 studies
- Washington, DC9 studies
Other studies in Tucson
- Obesity20 studies
- Breast Cancer18 studies
- Non-Small Cell Lung Cancer18 studies
- Overweight17 studies
- Metastatic Cancer14 studies
- Type 2 Diabetes13 studies
- Cancer (all types)12 studies
- Prostate Cancer12 studies
- Colorectal Cancer11 studies
- Cardiovascular Disease11 studies
- Steatotic Liver Disease10 studies
- Acute Myeloid Leukemia10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.